/Johnson%20%26%20Johnson%20location%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
With a market cap of $592.4 billion, New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a global healthcare company engaged in the research, development, manufacturing, and sale of a broad range of medical products worldwide. The company serves patients and healthcare professionals through hospitals, wholesalers, retailers, and clinics around the world.
Companies valued at $200 billion or more are generally considered “mega-cap” stocks and Johnson & Johnson fits this criterion perfectly. It operates through two main segments: Innovative Medicine, which focuses on therapies across areas such as oncology, immunology, neuroscience, and cardiovascular disease, and MedTech, which delivers solutions for surgery, orthopedics, cardiovascular care, and vision health.